Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.8661
-0.0310 (-3.46%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Werewolf Therapeutics Employees
Werewolf Therapeutics had 46 employees as of December 31, 2024. The number of employees decreased by 1 or -2.13% compared to the previous year.
Employees
46
Change (1Y)
-1
Growth (1Y)
-2.13%
Revenue / Employee
$40,978
Profits / Employee
-$1,532,935
Market Cap
39.93M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 46 | -1 | -2.13% |
| Dec 31, 2023 | 47 | 1 | 2.17% |
| Dec 31, 2022 | 46 | 7 | 17.95% |
| Dec 31, 2021 | 39 | 15 | 62.50% |
| Dec 31, 2020 | 24 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
HOWL News
- 9 days ago - Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer - GlobeNewsWire
- 26 days ago - Werewolf Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Werewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Werewolf Therapeutics to Present at the 2025 Leerink Partners Global Biopharma Conference - GlobeNewsWire
- 2 months ago - Werewolf Therapeutics Appoints Anil Singhal, Ph.D., to its Board of Directors - GlobeNewsWire
- 3 months ago - Werewolf Therapeutics Provides Business Update and Highlights 2025 Strategic Outlook - GlobeNewsWire
- 5 months ago - Werewolf Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Healthcare Conference - GlobeNewsWire
- 6 months ago - Werewolf Therapeutics Presents Preclinical and Clinical Data at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting - GlobeNewsWire